Internal Medicine, Gastroenterology · Pottsville, PA
NPI
1720050222
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
48 Tunnel Rd, Suite 104
Pottsville, PA, 17901
Phone (570) 622-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$298K
2,908 services
Medicare patients, 2024
1,342
Average age 73
Drug cost, 2024
$863K
3,208 prescriptions
Company payments, 2025
$2,210
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amrit P Narula was code 99214 (office e&m - established), 856 times for 368 patients. In total Amrit P Narula billed 2,908 services in 36 codes, and Medicare paid $298K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 856 | 368 | $80.72 | $69K |
| 43239 Upper GI Endoscopy | Facility | 409 | 389 | $89.52 | $37K |
| 99232 Hospital E&M - Subsequent | Facility | 349 | 133 | $58.90 | $21K |
| 45385 Colonoscopy - Lesion Removal | Facility | 246 | 241 | $192.34 | $47K |
| 99223 Hospital E&M - Initial | Facility | 214 | 176 | $126.22 | $27K |
| 45380 Lower GI Endoscopy - Other | Facility | 144 | 143 | $116.21 | $17K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 138 | 137 | $167.72 | $23K |
| 43235 Upper GI Endoscopy | Facility | 72 | 71 | $83.20 | $5,991 |
| 45378 Lower GI Endoscopy - Other | Facility | 70 | 66 | $108.27 | $7,579 |
| 43450 Digestive/Gastrointestinal | Facility | 69 | 66 | $28.94 | $1,997 |
| 43249 Upper GI Endoscopy | Facility | 62 | 57 | $103.83 | $6,438 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 61 | 61 | $159.74 | $9,744 |
| 99213 Office E&M - Established | Office | 59 | 59 | $54.79 | $3,232 |
| 99233 Hospital E&M - Subsequent | Facility | 25 | 23 | $86.76 | $2,169 |
| 99204 Office E&M - New | Office | 18 | 18 | $104.30 | $1,877 |
By year: 2022 $300K for 2,906 services; 2023 $301K for 2,813 services; 2024 $298K for 2,908 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amrit P Narula prescribed most often to Medicare patients was Pantoprazole Sodium, with 921 prescriptions and refills. In total Amrit P Narula wrote 3,208 Medicare prescriptions that cost $863K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 921 | 1,872 | 341 | $12K |
| Omeprazole Generic | 356 | 837 | 125 | $4,066 |
| Famotidine Generic | 287 | 514 | 107 | $2,870 |
| Lansoprazole Generic | 100 | 240 | 33 | $2,983 |
| Esomeprazole Magnesium Generic | 82 | 222 | 28 | $6,689 |
| Sucralfate Generic | 69 | 97 | 29 | $2,364 |
| Mesalamine Dr Mesalamine | 59 | 103 | 15 | $32K |
| Alprazolam Generic | 57 | 57 | Under 11 | $457 |
| Metoclopramide Hcl Generic | 55 | 85 | 23 | $303 |
| Linzess Linaclotide | 52 | 88 | 15 | $46K |
| Fluticasone Propionate Generic | 51 | 90 | 25 | $930 |
| Metoprolol Succinate Generic | 48 | 118 | 12 | $1,359 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 46 | 46 | 13 | $1,333 |
| Rosuvastatin Calcium Generic | 43 | 79 | Under 11 | $325 |
| Dexlansoprazole Dr Dexlansoprazole | 39 | 91 | 11 | $15K |
Brand drugs: - claims; generic drugs: 2,909 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amrit P Narula $2,210 ($2,210 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $417.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $417 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 21 | $361 |
| Janssen Biotech, Inc. JNJ | 15 | $316 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $184 |
| Ardelyx, Inc. ARDX | 6 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $112 |
| Aimmune Therapeutics, Inc. | 7 | $110 |
| Genzyme Corporation SNY | 3 | $81.79 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $81.51 |
| Madrigal Pharmaceuticals MDGL | 3 | $76.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.